Researcher profile
Roanne Keeton
Public evidence
2 connected articles
Safety, Effectiveness and Immunogenicity of heterologous mRNA-1273 Boost after Prime with Ad26.COV2.S among Healthcare Workers in South Africa: the single-arm, open-label, Phase 3 SHERPA Study2024 · medRxivHomologous Ad26.COV2.S vaccination results in reduced boosting of humoral responses in hybrid immunity, but elicits antibodies of similar magnitude regardless of prior infection2023 · medRxiv
Matched by exact identifiers only. Profile data: Corpus/OpenAlex.